Clinical Trials Logo
NCT number NCT03189901
Study type Interventional
Source Qilu Hospital of Shandong University
Contact Feng Xu, M.D.
Phone +86-18560083066
Status Not yet recruiting
Phase Phase 4
Start date July 1, 2017
Completion date July 1, 2018

Clinical Trial Summary

There are always poor outcomes in patients with acute myocardial infarction(AMI) combined with elevated BNP/NT-proBNP level. An elevated BNP/NT-proBNP level highly indicates acute heart failure(AHF).Levosimendan is recommended in many clinical trials of heart failure and Chinese heart failure guidelines. As a result, the investigators form a hypothesis that when patients with AMI combined with elevated BNP/NT-proBNP level are in conditions before AHF, to use levosimendan may reduces the risk of heart failure and improve the outcome.

Clinical Trial Description


Study Design

Related Conditions & MeSH terms

See also
Status Clinical Trial Phase
 Terminated NCT02151383 - Pharmacokinetics & Safety of Serelaxin on Top of Standard of Care Therapy in Pediatric Patients With Acute Heart Failure Phase 2
 Completed NCT02122640 - Evaluation of Acute Cardiogenic Dyspnoea With Thorax Echography and Pro-BNP in the Emergency Department N/A
 Not yet recruiting NCT01211886 - Utility of Brain Natriuretic Peptide (BNP) in Patients With Type IV Cardio-renal Syndrome Admitted to the Intensive Care Unit (ICU) N/A
 Completed NCT01193998 - Impact of Validated Diagnostic Prediction Model of Acute Heart Failure in the Emergency Department N/A
 Recruiting NCT00512759 - Goal-directed Afterload Reduction in Acute Congestive Cardiac Decompensation Study N/A
 Recruiting NCT03157219 - Manipal Heart Failure Registry (MHFR) N/A
 Active, not recruiting NCT02141607 - Evolution of Molecular Biomarkers in Acute Heart Failure Induced by Shock N/A
 Enrolling by invitation NCT02258984 - Can the Venus 1000 Help Clinicians Treat Patients With Severe Sepsis or Acute Heart Failure? The CVP Trial N/A
 Completed NCT01870778 - Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF Phase 3
 Completed NCT02350114 - An Observational Study of the Functional Capacity of Heart Failure N/A
 Recruiting NCT01704131 - Levosimendan Pharmacokinetics in Children N/A
 Completed NCT00561483 - Sequential Cystatin C Levels and Renal Impairment in Acute Heart Failure N/A
 Recruiting NCT02728739 - Incidence of Significant Mitral Regurgitation in Acute Heart Failure Patients N/A
 Withdrawn NCT02299726 - Early Aldosterone Blockade in Acute Heart Failure: An Exploratory Safety Study Phase 2
 Active, not recruiting NCT01834833 - Consultation at 8 Days to Reduce Hospitalisations in Heart Failure Patient N/A
 Completed NCT01614860 - Identification of Patient Phenotypes Associated With Elevated Aldosterone Levels N/A
 Completed NCT01619540 - Valsalva ManÅ“uvre in the Diagnosis of Left Ventricular Failure in Chronic Obstructive Pulmonary Disease Exacerbation N/A
 Completed NCT01363505 - Bladder Pressure Predicting Renal Failure in Critically Ill Patients as Compared to Hemodynamic Parameters N/A
 Completed NCT01127945 - Study to Evaluate the Effectiveness of High Dose Statin Loading in Acute Heart Failure Patients N/A
 Terminated NCT00083772 - Use of Nesiritide in the Management of Acute Diastolic Heart Failure Phase 4